Diabetes Care

Dapagliflozin and Metformin Combination Tablets and Reading Two Strengths

Understand what each number on a combination tablet means and how the exact formulation affects everyday use and safety checks.

By Global Medicines ExportUpdated: Educational article

Label-reading reference

What a combination label tells you

These are identification examples. The prescription and exact supplied product leaflet determine the tablet schedule.

Separate strength, formulation and quantity

Label featureWhat it meansWhat to check
Dapagliflozin 5 mg + metformin 1,000 mgTwo ingredient strengths in one tabletMatch each number to its ingredient
XR, ER, SR or PR wordingThe manufacturer describes a modified-release presentationExact formulation and whole-tablet instructions
A third named ingredientA different combination productAdditional effects, interactions and precautions
Pack quantityNumber of tablets suppliedKeep quantity separate from strength and daily amount

What does this combination do?

Dapagliflozin and metformin act in different ways to help control blood glucose in type 2 diabetes. Dapagliflozin increases glucose removal through the urine. Metformin reduces glucose production by the liver and improves the body's response to insulin. Combining them can make a prescription simpler when both ingredients and their fixed amounts fit the treatment plan.

The suitability of a combination depends on both ingredients. Its instructions may differ from those for dapagliflozin taken alone. This guide uses named UK Xigduo and US Xigduo XR reference information to show why the brand, country and release form matter. Your supplied product requires its own leaflet and prescription check.

How do you read 5 mg/1,000 mg on a pack?

Read the ingredient names in the order printed beside the strengths. If the label says dapagliflozin 5 mg and metformin hydrochloride 1,000 mg, those figures describe one tablet. They do not tell you the total daily prescribed amount until you also know the number of tablets and timing.

For an identification example, the Dapagliflozin 5 mg + Metformin 1000 mg Tablets listing can help you match the catalogue presentation. Give a pharmacist the full pack wording when checking it against a prescription. If a listing includes glimepiride as well, record that third ingredient and its strength separately.

As a hypothetical reading exercise, two tablets each labelled 5 mg/1,000 mg would contain a combined total of 10 mg dapagliflozin and 2,000 mg metformin across those two tablets. This arithmetic explains a label. It does not determine whether two tablets or that daily amount are prescribed or appropriate for a particular product.

Why do some leaflets give different meal and tablet schedules?

The UK Xigduo film-coated reference product is taken twice daily with meals. US Xigduo XR uses extended-release metformin and is taken once daily in the morning with food. These instructions describe different named formulations. A matching ingredient pair or similar strength on a website does not establish the same schedule.

Look for the release description on the carton and leaflet before comparing instructions. The metformin formulation guide explains IR, SR, ER and PR wording. Ask whether the supplied tablet must be swallowed whole and whether splitting is permitted for that exact product.

What changes when separate tablets become one combination?

Bring every current diabetes pack to the dispensing check. Ask the pharmacist to write down which separate products the new tablet replaces and which medicines continue. If you still have an older metformin or dapagliflozin prescription at home, keep it identifiable while you clarify the new plan.

A useful reconciliation record includes each active ingredient, strength per tablet, release form, tablets per dose and doses per day. Ask for one clear current list. This is especially helpful when hospital and primary-care prescriptions overlap or when a medicine is supplied under a different brand.

Which checks matter before and during treatment?

The US Xigduo XR label requires assessment of kidney function before starting and during treatment because kidney function affects the suitability of the combination. It also draws attention to fluid loss, particularly in people who take diuretics or have a higher risk of low blood pressure. Give the team your full medicine list and any recent kidney results.

HbA1c and glucose records help assess response. The guide to HbA1c and fasting blood sugar explains what those results measure. For metformin use over time, report new tingling, numbness, marked fatigue or a sore tongue so the clinician can consider whether B12 assessment or another investigation is appropriate.

What should your plan cover when you are unwell or fasting?

Discuss vomiting, diarrhoea, inability to drink, prolonged fasting and planned surgery before a problem arises. Ask which team to call, which medicines to pause if advised, and how to restart. Because both ingredients are in one tablet, instructions for temporarily withholding one component require a plan for the whole prescription.

US Xigduo XR instructions include withholding the medicine before surgery or procedures involving prolonged fasting. Contrast scans may also require a specific plan depending on kidney function and the procedure. Give the procedural team the exact product and last-dose date. Obtain restart instructions from the team responsible for your care.

Which symptoms require prompt help?

Seek urgent medical assessment for significant vomiting or abdominal pain with unusual breathing, marked weakness or confusion. Dapagliflozin-associated ketoacidosis can occur without a very high glucose reading, and metformin-associated lactic acidosis is another serious concern described in the reference labels. Tell the team the combination name and when you last took it.

Report genital irritation, recurrent thrush or urinary symptoms to a clinician. Get prompt help for fever with painful urination or back pain, and urgent help for severe pain, redness or swelling around the genitals or perineum with fever or feeling unwell. These symptoms need assessment rather than another dose chosen from an online guide.

What about low glucose, missed tablets and everyday follow-up?

Low glucose becomes a more important concern if the combination is used with insulin or a sulfonylurea. Ask for an individual low-glucose plan and explain when meals or activity change. The team may need to review the wider prescription. Carry the treatment for a low that your team recommends.

Use the missed-dose instructions in your exact leaflet. Avoid taking two doses together to compensate. If you are uncertain which tablets you took, or you have taken an extra dose, contact a pharmacist or urgent medical advice service with the pack and times available.

What details help identify a product for an enquiry?

Provide the ingredient pair, strength of each ingredient, release wording, manufacturer and pack quantity. If a third ingredient appears, name it separately. Include a clear pack photo where available and ask for the exact offered product leaflet.

For an international professional enquiry, add destination, quantity and required documentation. Clinical suitability, substitution and any destination approval or import requirements need checking for that particular presentation.

Export product support

Need product, pack, and documentation details?

Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.

Common questions

Does 5 mg/1,000 mg mean 1,005 mg of one medicine?

Each figure belongs to a different active ingredient. Keep the names and strengths paired when discussing a prescription or product.

Can I take my old metformin with a new combination tablet?

Have the pharmacist check your current list before taking overlapping products. The combination already contains metformin, and the prescriber must clarify which separate tablets continue.

Does a combination tablet always have an extended-release formulation?

Products differ. Check the manufacturer's full release wording on the carton and leaflet and follow the schedule for that formulation.

Can a glucose result near my usual range rule out ketoacidosis?

No. Seek urgent assessment if you have concerning symptoms such as vomiting, abdominal pain or unusual breathing, and tell staff that you take dapagliflozin.

Why might I need separate medicines again during a treatment change?

A fixed combination ties the ingredient amounts together. A clinician may use separate products when the components need different adjustment or interruption.

What if the next pack has different release letters?

Show the old and new packs to a pharmacist before changing your routine. Ask them to confirm the formulation, tablet count and timing.

Should I tell a scan or surgical team about this medicine?

Yes. Give the full combination name, strength and last-dose date. Ask for a written interruption and restart plan for your procedure.

If dapagliflozin alone is suitable for my kidney or heart condition, is the combination automatically suitable?

The metformin component adds its own eligibility and kidney-function considerations. The clinician must assess the combination as a whole using its exact label and your circumstances.

Important medical note

This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.

References